Medtronic (NYSE: MDT)+
announced that CMS is opening a national coverage analysis on renal denervation (RDN) procedures for patients with hypertension.
An Abbott (NYSE: ABT)+
official said on social media that the company secured a significant Medicare win for its CardioMEMS platform.
Biobot Surgical announced today that it received CE mark for its Mona Lisa 2.0 surgical robotic platform for urology applications.
TEL AVIV, Israel, Jan. 14, 2025 /PRNewswire/ — BAIBYS™, a pioneering Israeli startup in AI-powered micro-robotics for Artificial Reproductive Technology (ART), today announced it has received the CE mark for its innovative BAIBYS™ system.
Robeauté announced today that it raised $28 million to support the development of its neurosurgical microrobot technology.